Abstract
Background and Aims : Sarcopenia is a progressive disorder involving the accelerated loss of muscle mass and function. Sarcopenia becomes more frequent by ageing. Sarcopenia is associated with inflammation and increased risk for coronary artery disease. Sarcopenia may be diagnosed by several techniques including measurement of spinal muscle area in computed tomography (CT) images. We aimed to evaluate relationship between sarcopenia and vascular calcification in patients scheduled for TAVR.Methods: All of the patients who underwent CT for TAVR planning between 2013 and 2020 were screened and skeletal muscle area at L3 vertebrae level was measured. Parameters regarding vascular calcification were also measured from CT images.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Conclusions: Sarcopenia is an important marker of vascular calcification and it may be measured easily from CT images performed for any indication. MAC and all-cause mortality rate during follow-uo are more frequent in patients with sarcopenia. Background and Aims : Sarcopenia is a progressive disorder involving the accelerated loss of muscle mass and function. Sarcopenia becomes more frequent by ageing. Sarcopenia is associated with inflammation and increased risk for coronary artery disease. Sarcopenia may be diagnosed by several techniques including measurement of spinal muscle area in computed tomography (CT) images. We aimed to evaluate relationship between sarcopenia and vascular calcification in patients scheduled for TAVR. Methods: All of the patients who underwent CT for TAVR planning between 2013 and 2020 were screened and skeletal muscle area at L3 vertebrae level was measured. Parameters regarding vascular calcification were also measured from CT images. Conclusions: Sarcopenia is an important marker of vascular calcification and it may be measured easily from CT images performed for any indication. MAC and all-cause mortality rate during follow-uo are more frequent in patients with sarcopenia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
